O
Olivier Cointault
Researcher at University of Toulouse
Publications - 97
Citations - 4608
Olivier Cointault is an academic researcher from University of Toulouse. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 30, co-authored 88 publications receiving 4097 citations. Previous affiliations of Olivier Cointault include Novartis & Paul Sabatier University.
Papers
More filters
Journal ArticleDOI
Hepatitis E virus and chronic hepatitis in organ-transplant recipients.
Nassim Kamar,Janick Selves,Jean-Michel Mansuy,Leila Ouezzani,Jean-Marie Péron,Joelle Guitard,Olivier Cointault,Laure Esposito,Florence Abravanel,Marie Danjoux,Dominique Durand,Jean-Pierre Vinel,Jacques Izopet,Lionel Rostaing +13 more
TL;DR: The time from transplantation to diagnosis was significantly shorter and the total counts of lymphocytes and of CD2, CD3, and CD4 T cells were significantly lower in patients in whom chronic disease developed.
Journal ArticleDOI
Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection.
Nassim Kamar,Lionel Rostaing,Lionel Rostaing,Florence Abravanel,Florence Abravanel,Cyril Garrouste,Sébastien Lhomme,Laure Esposito,G. Basse,Olivier Cointault,David Ribes,Marie Béatrice Nogier,Laurent Alric,Jean-Marie Peron,Jacques Izopet,Jacques Izopet +15 more
TL;DR: Ribavirin monotherapy inhibits the replication of HEV in vivo and might induce a sustained virological response in patients with chronic HEV infections.
Journal ArticleDOI
Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients.
Nassim Kamar,Jean-Michel Mansuy,Olivier Cointault,J. Selves,Florence Abravanel,Marie Danjoux,Phillippe Otal,L. Esposito,Dominique Durand,Jacques Izopet,Lionel Rostaing +10 more
TL;DR: It is concluded that HEV infection cannot only evolve to chronic hepatitis, but can also be responsible for rapidly progressing cirrhosis in organ‐transplant patients.
Journal ArticleDOI
Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation
Nassim Kamar,Florence Abravanel,Janick Selves,Cyril Garrouste,Laure Esposito,Laurence Lavayssière,Olivier Cointault,David Ribes,I. Cardeau,Marie Béatrice Nogier,Jean Michel Mansuy,Fabrice Muscari,Jean-Marie Péron,Jacques Izopet,Lionel Rostaing +14 more
TL;DR: The rate of chronic HEV-related hepatitis is approximately 60% in solid-organ transplant patients, and the reduction of immunosuppressive drugs targeting T cells should be considered as a first-line therapeutic option.
Journal ArticleDOI
Rituximab therapy for acute humoral rejection after kidney transplantation
Stanislas Faguer,Nassim Kamar,Céline Guilbeaud-Frugier,Marylise Fort,Anne Modesto,Arnaud Mari,David Ribes,Olivier Cointault,Laurence Lavayssière,Joelle Guitard,Dominique Durand,Lionel Rostaing +11 more
TL;DR: Rituximab therapy, in addition to PE, might be of benefit for RT patients presenting with AHR, and DSA had disappeared or decreased in four cases.